We are live on
!
Find out more
RJFSA
Raymond James Financial Services Advisors Portfolio holdings
AUM
$75.1B
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+20.17%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$31.5B
AUM Growth
+$8.55B
(+37%)
Cap. Flow
+$4.25B
Cap. Flow
% of AUM
13.49%
Top 10 Holdings %
Top 10 Hldgs %
18.78%
Holding
2,958
New
539
Increased
1,172
Reduced
1,031
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$221M |
| 2 |
Cisco
CSCO
|
+$197M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$173M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$137M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$79.4M |
| 2 |
First Trust Value Line Dividend Fund
FVD
|
+$29.8M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$24.3M |
| 4 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$21.7M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.34% |
| 2 | Healthcare | 6.55% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.66% |
| 5 | Industrials | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Invesco Biotechnology & Genome ETF
PBE
$359M
| $573K | ﹤0.01% |
9,832
-1,560
| -14% | -$85K |
|
|
CMA
1827
DELISTED
Comerica
CMA
| $572K | ﹤0.01% |
15,010
-1,910
| -11% | -$66.6K |
|
1828
Cleveland-Cliffs
CLF
$6.93B
| $571K | ﹤0.01% |
103,507
+5,920
| +6% | +$28.8K |
|
1829
Cheniere Energy
LNG
$55B
| $571K | ﹤0.01% |
11,813
-37
| -0.3% | -$1.62K |
|
1830
Mine Safety
MSA
$7.32B
| $571K | ﹤0.01% |
4,993
+82
| +2% | +$9.12K |
|
|
PCK
1831
DELISTED
Pimco California Municipal Income Fund II
PCK
| $570K | ﹤0.01% |
64,556
+44,926
| +229% | +$380K |
|
|
AJRD
1832
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $570K | ﹤0.01% |
14,381
-390
| -3% | -$16.2K |
|
1833
Fresenius Medical Care
FMS
$12.6B
| $569K | ﹤0.01% |
13,156
+5,617
| +75% | +$222K |
|
|
SGMO
1834
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $568K | ﹤0.01% |
63,448
+17,496
| +38% | +$162K |
|
1835
Enphase Energy
ENPH
$5.39B
| $567K | ﹤0.01% |
11,920
-2,701
| -18% | -$129K |
|
1836
Oshkosh
OSK
$9.41B
| $567K | ﹤0.01% |
7,911
-18,889
| -70% | -$1.29M |
|
|
UFOX
1837
Defiance Space and Connective Tech ETF
UFOX
$922M
| $566K | ﹤0.01% |
20,750
+211
| +1% | +$5.34K |
|
1838
Nuveen AMT-Free Municipal Value Fund
NUW
$251M
| $565K | ﹤0.01% |
36,117
+2,745
| +8% | +$41.3K |
|
1839
Upland Software
UPLD
$14.9M
| $565K | ﹤0.01% |
1,627
+418
| +35% | +$130K |
|
|
IGR
1840
CBRE Global Real Estate Income Fund
IGR
$715M
| $564K | ﹤0.01% |
94,509
-6,574
| -7% | -$37.5K |
|
1841
CACI
CACI
$15B
| $562K | ﹤0.01% |
2,592
+828
| +47% | +$198K |
|
|
CIM
1842
Chimera Investment
CIM
$993M
| $559K | ﹤0.01% |
19,379
-1,197
| -6% | -$30.8K |
|
1843
Jabil
JBL
$38.8B
| $559K | ﹤0.01% |
17,427
-8
| -0% | -$230 |
|
|
IVH
1844
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
| $559K | ﹤0.01% |
49,776
+314
| +0.6% | +$3.42K |
|
1845
Nuveen Real Asset Income & Growth Fund
JRI
$349M
| $558K | ﹤0.01% |
47,782
+7,014
| +17% | +$77.9K |
|
1846
Thor Industries
THO
$4.11B
| $558K | ﹤0.01% |
5,238
-3,677
| -41% | -$288K |
|
1847
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$263M
| $557K | ﹤0.01% |
7,302
-23,428
| -76% | -$1.69M |
|
1848
HEICO Corp
HEI
$52.1B
| $556K | ﹤0.01% |
5,581
-30,591
| -85% | -$2.82M |
|
1849
LGI Homes
LGIH
$1.32B
| $556K | ﹤0.01% |
6,313
-700
| -10% | -$49.1K |
|
1850
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.08B
| $556K | ﹤0.01% |
23,195
-17,255
| -43% | -$383K |
|
Similar funds
PI
ECU
EAM
AA
SA
WPL
ECU
RJT
Raymond James Financial Services Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Raymond James Financial Services Advisors held 2,958 positions worth $31.5B, up 37% from $22.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Raymond James Financial Services Advisors deployed $4.25B of net new capital in Q2 2020, opening 539 new positions and adding to 1,172 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 3,507,464 shares worth $240M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $79.4M trimmed.
- Raymond James Financial Services Advisors's largest Q2 2020 buy was iShares Core S&P Small-Cap ETF: 3,507,464 shares worth $240M.
- Raymond James Financial Services Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $127M increase.
- Raymond James Financial Services Advisors's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.4M.
- Raymond James Financial Services Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $15.5M.
- Raymond James Financial Services Advisors's ten largest holdings make up 19% of its $31.5B portfolio in Q2 2020.
- Raymond James Financial Services Advisors opened 539 new positions and closed 140 in Q2 2020.
- Raymond James Financial Services Advisors's portfolio value rose 37% quarter-over-quarter to $31.5B.
Based on Raymond James Financial Services Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.